Publication | Closed Access
Dendritic cell–based immunotherapy targeting Wilms’ tumor 1 in patients with recurrent malignant glioma
86
Citations
35
References
2015
Year
This study of WT1-pulsed DC vaccination therapy demonstrated safety, immunogenicity, and feasibility in the management of relapsed malignant gliomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1